News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Publication Nov 6, 2024 Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Christopher Ma, Vipul Jairath, Virginia Salitano Read Now
Publication Apr 24, 2023 Real-World Multicentre Observational Study With Pop-PK Modelling to Evaluate the Exposure-Response Relationship of Vedolizumab in IBD Brian Feagan, Niels Vande Casteele Read Now
Publication Apr 19, 2023 Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn’s Disease: A Systematic Review and Meta-Analysis Christopher Ma, Malcolm Hogan, Vipul Jairath Read Now
Publication Apr 17, 2023 ATRC Review: IL-12 and IL-23 pathway inhibition in inflammatory bowel disease Alimentiv Translational Research Consortium (ATRC), Niels Vande Casteele Read Now
Publication Apr 6, 2023 Existing Bowel Preparation Quality Scales Are Reliable in the Setting of Centralized Endoscopy Reading Brian Feagan, Christopher Ma, Guangyong Zou, Lisa M Shackelton, Vipul Jairath Read Now
Publication Apr 1, 2023 Endoscopic and Histological Placebo Rates in Crohn’s Disease Clinical Trials: A Systematic Review and Meta-analysis Brian G Feagan, Christopher Ma, Vipul Jairath Read Now
Publication Feb 8, 2023 Patients With Crohn’s Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic Review Christopher Ma, Eileen Crowley, Vipul Jairath Read Now
